Literature DB >> 5031659

Successful treatment of candidiasis with transfer factor.

H F Pabst, R Swanson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5031659      PMCID： PMC1788037          DOI： 10.1136/bmj.2.5811.442

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  Chronic mucocutaneous candidiasis, deficiency of delayed hypersensitivity, and selective local antibody defect.

Authors:  R A Chilgren; P G Quie; H J Meuwissen; R Hong
Journal:  Lancet       Date:  1967-09-30       Impact factor: 79.321

2.  Lymphocyte abnormality in chronic mucocutaneous candidiasis.

Authors:  H Valdimarsson; L Holt; H R Riches; J R Hobbs
Journal:  Lancet       Date:  1970-06-13       Impact factor: 79.321

3.  Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: immunological reconstitution by allogeneic bone marrow.

Authors:  R H Buckley; Z J Lucas; B G Hattler; C M Zmijewski; D B Amos
Journal:  Clin Exp Immunol       Date:  1968-02       Impact factor: 4.330

4.  The cellular immune defect in chronic mucocutaneous candidiasis.

Authors:  R A Chilgren; H J Meuwissen; P G Quie; R A Good; R Hong
Journal:  Lancet       Date:  1969-06-28       Impact factor: 79.321

Review 5.  Chronic mucocutaneous candidiasis: model-building in cellular immunity.

Authors:  C H Kirkpatrick; R R Rich; J E Bennett
Journal:  Ann Intern Med       Date:  1971-06       Impact factor: 25.391

6.  Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro.

Authors:  R E Rocklin; R A Chilgren; R Hong; J R David
Journal:  Cell Immunol       Date:  1970-09       Impact factor: 4.868

7.  Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor.

Authors:  A S Levin; L E Spitler; D P Stites; H H Fudenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205
  7 in total
  7 in total

1.  Double-blind trial of the use of transfer factor in the treatment of Crohn's disease.

Authors:  F R Vicary; J D Chambers; P Dhillon
Journal:  Gut       Date:  1979-05       Impact factor: 23.059

2.  [Kinetic study of the delayed type hypersensitivity in experimental candidiasis of the mouse].

Authors:  F E Floc'h; J Biguet; S Andrieu; A Vernes
Journal:  Mycopathol Mycol Appl       Date:  1974-12-18

Review 3.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1973-05       Impact factor: 2.401

4.  In vitro properties of leukocyte dialysates containing transfer factor.

Authors:  M S Ascher; W J Schneider; F T Valentine; H S Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

5.  Transfer of maternal specific cell-mediated immunity to the fetus.

Authors:  H F Pabst; J C Godel; D W Spady; K Cho
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

6.  [Transfer factor (TF) treatment of patients with HBs-Ag-positive chronic active hepatitis. A prospective, controlled study (author's transl)].

Authors:  C P Sodomann; G Maerker-Alzer; K Havemann; C Dienst; H Schultz; D Mitrenga; K Schumacher; G A Martini
Journal:  Klin Wochenschr       Date:  1979-09-03

7.  Effect of transfer factor on lymphocyte function in anergic patients.

Authors:  C H Kirkpatrick; R R Rich; T K Smith
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.